These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 29658564

  • 1. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
    Shi H, Mao Y, Ju Q, Wu Y, Bai W, Wang P, Zhang Y, Jiang M.
    Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
    [Abstract] [Full Text] [Related]

  • 2. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
    Guan C, Shi H, Wang H, Zhang J, Ni W, Chen B, Hou S, Yang X, Shen A, Ni R.
    J Cell Biochem; 2013 Jun; 114(6):1343-54. PubMed ID: 23255392
    [Abstract] [Full Text] [Related]

  • 3. CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway.
    Ju Q, Jiang M, Huang W, Yang Q, Luo Z, Shi H.
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34878149
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
    Liu L, Ju Y, Wang J, Zhou R.
    Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
    [Abstract] [Full Text] [Related]

  • 5. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
    Li DJ, Shi M, Wang Z.
    Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
    [Abstract] [Full Text] [Related]

  • 6. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.
    Zhang J, Zhu J, Yang L, Guan C, Ni R, Wang Y, Ji L, Tian Y.
    Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824
    [Abstract] [Full Text] [Related]

  • 7. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K, Yang Y, Zhao J, Zhao S.
    Cancer Lett; 2016 Feb 01; 371(1):125-33. PubMed ID: 26655271
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of ALDH5A1 suppresses cisplatin resistance in esophageal squamous cell carcinoma by regulating ferroptosis signaling pathways.
    Song K, Ma C, Maswikiti EP, Gu B, Wang B, Wang N, Jiang P, Chen H.
    Mol Carcinog; 2024 Oct 01; 63(10):1892-1906. PubMed ID: 38923019
    [Abstract] [Full Text] [Related]

  • 9. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
    Yang C, Shen S, Zheng X, Ye K, Ge H, Sun Y, Lu Y.
    FASEB J; 2020 May 01; 34(5):6055-6069. PubMed ID: 32239565
    [Abstract] [Full Text] [Related]

  • 10. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
    Chen L, Ni S, Li M, Shen C, Lin Z, Ouyang Y, Xia F, Liang L, Jiang W, Ni R, Zhang J.
    Dig Dis Sci; 2017 Feb 01; 62(2):387-395. PubMed ID: 27995408
    [Abstract] [Full Text] [Related]

  • 11. LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.
    Li Y, Chen D, Gao X, Li X, Shi G.
    Dis Markers; 2017 Feb 01; 2017():5314649. PubMed ID: 29147064
    [Abstract] [Full Text] [Related]

  • 12. Effect of altered WIG-1 expression on DDP sensitivity in a DDP-resistant esophageal squamous cancer cell line.
    Qiu Y, Zou YB, Li K, Jiang YG, Yang K, Zhao YP, Guo W.
    Curr Cancer Drug Targets; 2012 Oct 01; 12(8):950-61. PubMed ID: 22794122
    [Abstract] [Full Text] [Related]

  • 13. ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA.
    Hou XF, Xu LP, Song HY, Li S, Wu C, Wang JF.
    World J Gastroenterol; 2017 Mar 14; 23(10):1796-1803. PubMed ID: 28348485
    [Abstract] [Full Text] [Related]

  • 14. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S, Akhtar J, Wang Z.
    Tumour Biol; 2015 Sep 14; 36(10):7797-806. PubMed ID: 25944168
    [Abstract] [Full Text] [Related]

  • 15. miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2.
    Jiang M, Shi H, Xu Y, Bai W, Wang P, Ju Q.
    Transl Cancer Res; 2019 Dec 14; 8(8):2791-2802. PubMed ID: 35117036
    [Abstract] [Full Text] [Related]

  • 16. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
    Tang NN, Zhu H, Zhang HJ, Zhang WF, Jin HL, Wang L, Wang P, He GJ, Hao B, Shi RH.
    World J Gastroenterol; 2014 Dec 21; 20(47):17894-904. PubMed ID: 25548487
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of autophagy regulating chemoresistance in esophageal cancer cells.
    Fang F, Li Y, Chang L.
    Exp Mol Pathol; 2020 Dec 21; 117():104564. PubMed ID: 33137292
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of RUNX3 inhibits malignant behaviour of Eca109 cells in vitro and vivo.
    Chen HX, Wang S, Wang Z, Zhang ZP, Shi SS.
    Asian Pac J Cancer Prev; 2014 Dec 21; 15(4):1531-7. PubMed ID: 24641363
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
    Liu F, Zheng S, Liu T, Liu Q, Liang M, Li X, Sheyhidin I, Lu X, Liu W.
    Mol Cell Biochem; 2013 Sep 21; 381(1-2):115-25. PubMed ID: 23709326
    [Abstract] [Full Text] [Related]

  • 20. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
    Fu S, Jin L, Gong T, Pan S, Zheng S, Zhang X, Yang T, Sun Y, Wang Y, Guo J, Hui B, Zhang X.
    Oncol Rep; 2018 Apr 21; 39(4):1601-1608. PubMed ID: 29393484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.